Hybrid care model: Combining telemedicine and office visits for diabetes management in older adults with type 1 diabetes
Main Article Content
Abstract
Aims: To evaluate the use of hybrid (telehealth and in-person) care on visitation and glycaemia in older adults with type 1 diabetes (T1D).
Methods: In this retrospective study, we examined clinical characteristics, number of visits (telehealth and in-person) and continuous glucose monitoring (CGM) metrics for older adults (≥65 years) with T1D from electronic health records during the pre-COVID-19 pandemic (March 1, 2019-March 1, 2020; in-person) and pandemic (September 1, 2020-August 31, 2021; hybrid) periods. Main outcomes were the number of visits and changes in glycaemic control (HbA1c), and in a sub-group of older adults using CGM, changes in CGM metrics between in-person and hybrid care.
Results: We analysed data of 661 older adults with T1D (age 72±5 years). The hybrid care resulted in an increased number of annual diabetes visits (6.3 vs 4.2 visits/person) without change in glycaemic control (HbA1c 7.4% vs 7.2%) compared with in-person care alone. In the sub-group of 299 older adults with T1D using CGM, hybrid care compared with in-person care resulted in an improvement of time-in-range (70-180 mg/dL) (68% to 71%; p<0.001) without increasing hypoglycaemia (<70 mg/dL).
Conclusion: Compared with in-person only visits, hybrid care maintained visit frequency and preserved glycaemic control measured as HbA1c. In a sub-group of older adults with T1D using CGM, time-in-range improved while time in hypoglycaemia did not change. These data suggest that a hybrid care model is efficacious in maintaining visitation and glycaemic control, and, as demonstrated in a sub-group of older adults with T1D using CGM, safe with respect to time in hypoglycaemia.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. ElSayed NA, Aleppo G, Aroda VR, et al. 13. Older Adults: Standards of Care in Diabetes-2023. Diabetes Care. Jan 1 2023;46(Suppl 1):S216-S229. doi:10.2337/dc23-S013
3. Schutt M, Fach EM, Seufert J, et al. Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes. Diabet Med. Aug 2012;29(8):e176-9. doi:10.1111/j.1464-5491.2012.03681.x
4. Fisher L, Hessler D, Polonsky W, Strycker L, Masharani U, Peters A. Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. J Diabetes Complications. Aug 2016;30(6):1123-8. doi:10.1016/j.jdiacomp.2016.03.032
5. Mehrotra A, Bhatia RS, Snoswell CL. Paying for Telemedicine After the Pandemic. JAMA. Feb 2 2021;325(5):431-432. doi:10.1001/jama.2020.25706
6. Sotomayor F, Hernandez R, Malek R, Parimi N, Spanakis EK. The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era-A Systematic Review. J Clin Med. Aug 31 2023;12(17)doi:10.3390/jcm12175673
7. Jaana M, Pare G. Comparison of Mobile Health Technology Use for Self-Tracking Between Older Adults and the General Adult Population in Canada: Cross-Sectional Survey. JMIR Mhealth Uhealth. Nov 27 2020;8(11):e24718. doi:10.2196/24718
8. Lam K, Lu AD, Shi Y, Covinsky KE. Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic. JAMA Intern Med. Oct 1 2020;180(10):1389-1391. doi:10.1001/jamainternmed.2020.2671
9. Vigersky RA, Fish L, Hogan P, et al. The clinical endocrinology workforce: current status and future projections of supply and demand. J Clin Endocrinol Metab. Sep 2014;99(9):3112-21. doi:10.1210/jc.2014-2257
10. Lee JY, Lee SWH. Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review. Diabetes Technol Ther. Jul 2018;20(7):492-500. doi:10.1089/dia.2018.0098
11. Bonora BM, Morieri ML, Avogaro A, Fadini GP. The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy. Diabetes Care. Jan 2021;44(1):e18-e21. doi:10.2337/dc20-1872
12. Bertuzzi F, Stefani I, Rivolta B, et al. Teleconsultation in type 1 diabetes mellitus (TELEDIABE). Acta Diabetol. Feb 2018;55(2):185-192. doi:10.1007/s00592-017-1084-9
13. Pratley RE, Kanapka LG, Rickels MR, et al. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. Jun 16 2020;323(23):2397-2406. doi:10.1001/jama.2020.6928
14. Xu T, Pujara S, Sutton S, Rhee M. Telemedicine in the Management of Type 1 Diabetes. Prev Chronic Dis. Jan 25 2018;15:E13. doi:10.5888/pcd15.170168
15. Kaushal T, Ambler-Osborn L, Turcotte C, Quinn H, Laffel L. Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series. Telemed J E Health. Jan 2022;28(1):107-114. doi:10.1089/tmj.2020.0554
16. Kaushal T, Tinsley L, Volkening LK, Ambler-Osborn L, Laffel L. Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes During 1 Year of the COVID-19 Pandemic. Diabetes Technol Ther. Feb 2022;24(2):136-139. doi:10.1089/dia.2021.0258
17. Kaushal T, Tinsley LJ, Volkening LK, Turcotte C, Laffel LM. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19. J Clin Endocrinol Metab. Sep 28 2022;107(10):e4197-e4202. doi:10.1210/clinem/dgac476
18. Toschi E, Adam A, Atakov-Castillo A, Slyne C, Laffel L, Munshi M. Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter? Telemed J E Health. Jan 24 2023;doi:10.1089/tmj.2022.0397
19. Nouri S, Lyles CR, Sherwin EB, et al. Visit and Between-Visit Interaction Frequency Before and After COVID-19 Telehealth Implementation. JAMA Netw Open. Sep 5 2023;6(9):e2333944. doi:10.1001/jamanetworkopen.2023.33944
20. Toschi E, Slyne C, Weinger K, et al. Use of Telecommunication and Diabetes-Related Technologies in Older Adults With Type 1 Diabetes During a Time of Sudden Isolation: Mixed Methods Study. JMIR Diabetes. Nov 18 2022;7(4):e38869. doi:10.2196/38869
21. Aleppo G, Gal RL, Raghinaru D, et al. Comprehensive Telehealth Model to Support Diabetes Self-Management. JAMA Netw Open. Oct 2 2023;6(10):e2336876. doi:10.1001/jamanetworkopen.2023.36876
22. Munshi M, Slyne C, Weinger K, et al. Self-care barriers and facilitators in older adults with T1D during a time of sudden isolation. Sci Rep. Apr 29 2023;13(1):7026. doi:10.1038/s41598-023-33746-3